Published in J Virol on January 01, 1981
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J (1987) 4.60
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site. J Virol (1982) 4.06
Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. Proc Natl Acad Sci U S A (1987) 3.84
Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci U S A (1983) 3.42
Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28
Cloning and nucleotide sequencing of the bovine growth hormone gene. Nucleic Acids Res (1982) 2.91
A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. Proc Natl Acad Sci U S A (1983) 2.79
The region of mouse mammary tumor virus DNA containing the long terminal repeat includes a long coding sequence and signals for hormonally regulated transcription. EMBO J (1982) 2.76
Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci U S A (1981) 2.63
Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol (1991) 2.56
Activation of related transforming genes in mouse and human mammary carcinomas. Proc Natl Acad Sci U S A (1981) 2.41
Glucocorticoid receptors recognize DNA sequences in and around murine mammary tumour virus DNA. EMBO J (1982) 2.21
Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J Virol (1983) 2.20
Nucleotide sequence of the Syrian hamster intracisternal A-particle gene: close evolutionary relationship of type A particle gene to types B and D oncovirus genes. J Virol (1985) 2.20
Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region. EMBO J (1983) 2.12
Structural organization of transposable element mdg4 from Drosophila melanogaster and a nucleotide sequence of its long terminal repeats. Nucleic Acids Res (1984) 2.05
Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the rat. Proc Natl Acad Sci U S A (1983) 1.99
Purified glucocorticoid receptor-hormone complex from rat liver cytosol binds specifically to cloned mouse mammary tumor virus long terminal repeats in vitro. Proc Natl Acad Sci U S A (1982) 1.97
Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function. J Virol (1982) 1.94
Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci U S A (1988) 1.73
Nucleotide sequences of the retroviral long terminal repeats and their adjacent regions. Nucleic Acids Res (1984) 1.72
Specific transcriptional initiation in vitro on murine type C retrovirus promoters. Proc Natl Acad Sci U S A (1981) 1.71
Nucleotide sequences of feline sarcoma virus long terminal repeats and 5' leaders show extensive homology to those of other mammalian retroviruses. J Virol (1983) 1.71
Glucocorticoid regulation of transcription at an amplified, episomal promoter. Mol Cell Biol (1983) 1.66
Structure and expression of mouse VL30 genes. Mol Cell Biol (1983) 1.62
Further evidence for the protein coding potential of the mouse mammary tumor virus long terminal repeat: nucleotide sequence of an endogenous proviral long terminal repeat. J Virol (1983) 1.59
Sequence and expression of the mouse mammary tumour virus env gene. EMBO J (1983) 1.58
Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA. J Virol (1983) 1.55
Functional analysis of the steroid hormone control region of mouse mammary tumor virus. Nucleic Acids Res (1984) 1.54
The uteroglobin gene region: hormonal regulation, repetitive elements and complete nucleotide sequence of the gene. Nucleic Acids Res (1983) 1.52
Glucocorticoids and chromosomal position modulate murine mammary tumor virus transcription by affecting efficiency of promoter utilization. Mol Cell Biol (1983) 1.48
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45
Nucleotide sequence of the 5' noncoding region and part of the gag gene of mouse mammary tumor virus; identification of the 5' splicing site for subgenomic mRNAs. Nucleic Acids Res (1983) 1.45
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat. J Virol (1986) 1.43
Repeated consensus sequence and pseudopromoters in the four coordinately regulated tubulin genes of Chlamydomonas reinhardi. Mol Cell Biol (1984) 1.43
Modulation of enhancer activity by the hormone responsive regulatory element from mouse mammary tumor virus. EMBO J (1984) 1.40
Multiple regulatory domains in the mouse mammary tumor virus long terminal repeat revealed by analysis of fusion genes in transgenic mice. Mol Cell Biol (1988) 1.39
Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements. J Virol (1983) 1.38
Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A (1992) 1.37
Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns. J Virol (1988) 1.35
Primary structure of the soybean nodulin-23 gene and potential regulatory elements in the 5'-flanking regions of nodulin and leghemoglobin genes. Nucleic Acids Res (1985) 1.34
Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Mol Cell Biol (1991) 1.34
Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat. J Virol (1985) 1.32
The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J Exp Med (1992) 1.30
Purification and translation of murine mammary tumor virus mRNA's. J Virol (1981) 1.29
Isolation and characterization of the rat tryptophan oxygenase gene. EMBO J (1982) 1.26
Structure of the baboon endogenous virus genome: nucleotide sequences of the long terminal repeat. Nucleic Acids Res (1981) 1.25
Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med (1992) 1.24
Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene. Nucleic Acids Res (1983) 1.22
Nucleotide sequence analysis of the long terminal repeat of integrated simian sarcoma virus: evolutionary relationship with other mammalian retroviral long terminal repeats. J Virol (1982) 1.22
Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol (2003) 1.22
Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-O-tetradecanoyl phorbol-13-acetate. J Virol (1984) 1.19
Characterization, chromosome assignment, and segregation analysis of endogenous proviral units of mouse mammary tumor virus. J Virol (1986) 1.19
fim-1 and fim-2: two new integration regions of Friend murine leukemia virus in myeloblastic leukemias. J Virol (1986) 1.18
Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res (1991) 1.16
Terminal amino acid sequences and proteolytic cleavage sites of mouse mammary tumor virus env gene products. J Virol (1983) 1.14
Dexamethasone induction of the intracellular RNAs of mouse mammary tumor virus. J Virol (1981) 1.10
Transcriptional activity of the human pseudogene psi alpha globin compared with alpha globin, its functional gene counterpart. Nucleic Acids Res (1983) 1.06
The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. J Virol (1998) 1.03
Insertion elements and transitions in cloned mouse mammary tumour virus DNA: further delineation of the poison sequences. Nucleic Acids Res (1986) 1.02
Factors controlling the expression of mouse mammary tumour virus. Biochem J (1992) 1.02
Proteins encoded by the long terminal repeat region of mouse mammary tumor virus: identification by hybrid-selected translation. J Virol (1984) 1.01
Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. J Virol (1991) 1.01
Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences. J Virol (1984) 1.00
Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene. J Virol (1991) 1.00
A common mechanism for the enhancement of mRNA 3' processing by U3 sequences in two distantly related lentiviruses. J Virol (1996) 1.00
A transcriptionally defective long terminal repeat within an endogenous copy of mouse mammary tumor virus proviral DNA. J Virol (1988) 0.97
Expression of the protein product of the mouse mammary tumor virus long terminal repeat gene in phorbol ester-treated mouse T-cell-leukemia cells. J Virol (1986) 0.96
Expression of xenotropic-like env RNA sequences in normal DBA/2 and NZB mouse tissues. J Virol (1984) 0.95
naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region. J Virol (1990) 0.92
Selection of sequence elements that substitute for the standard AATAAA motif which signals 3' processing and polyadenylation of late simian virus 40 mRNAs. Nucleic Acids Res (1985) 0.91
Virus-encoded superantigens. Microbiol Rev (1996) 0.89
Amplification of mouse mammary tumor virus genomes in non-mammary tumor cells. J Virol (1989) 0.88
Conservation of protein coding potential in the long terminal repeats of exogenous and endogenous mouse mammary tumor viruses. J Virol (1982) 0.87
Transactivating potential of the 3' open reading frame of murine mammary tumor virus. J Virol (1988) 0.85
ICM Web: the interactive chromatin modeling web server. Nucleic Acids Res (2010) 0.84
Acquired Mls-1a-like clonal deletion in Mls-1b mice. J Exp Med (1992) 0.84
Identification of a unique mouse mammary tumor virus in the BALB/cNIV mouse strain. J Virol (1982) 0.84
Organization and expression of mouse mammary tumor virus sequences in normal and neoplastic C3Hf/HeSed mouse tissues. J Virol (1984) 0.84
Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis (1993) 0.83
Molecular cloning of the unintegrated squirrel monkey retrovirus genome: organization and distribution of related sequences in primate DNAs. J Virol (1983) 0.82
Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat. Proc Natl Acad Sci U S A (1995) 0.81
Nonrandom distribution of MMTV proviral sequences in the mouse genome. Nucleic Acids Res (1987) 0.81
Isolation of a pathogenic clone of mouse mammary tumor virus. J Virol (1989) 0.80
Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor. J Virol (1998) 0.80
Nucleotide sequence analysis of squirrel monkey retrovirus reveals a novel primer-binding site for tRNALys1,2. J Virol (1986) 0.79
Complete Nucleotide Sequence of Mouse Mammary Tumor Virus from JYG Chinese Wild Mice: Absence of Bacterial Insertion Sequences in the Cloned Viral gag Gene. Breast Cancer (1994) 0.79
Asymmetric transcription of mouse mammary tumor virus genes in vivo and in vitro. J Virol (1984) 0.79
Expression of the int-1 and int-2 loci in endogenous mouse mammary tumor virus-induced mammary tumorigenesis in the C3Hf mouse. J Virol (1989) 0.78
A comparison of nucleoside (beta-S)triphosphates and nucleoside (gamma-S)triphosphates as suitable substrates for measuring transcription initiation in preparations of cell nuclei. Nucleic Acids Res (1982) 0.78
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Screening lambdagt recombinant clones by hybridization to single plaques in situ. Science (1977) 83.82
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Regulatory sequences involved in the promotion and termination of RNA transcription. Annu Rev Genet (1979) 54.83
Calcium-dependent bacteriophage DNA infection. J Mol Biol (1970) 53.43
The use of thin acrylamide gels for DNA sequencing. FEBS Lett (1978) 40.52
The isolation of structural genes from libraries of eucaryotic DNA. Cell (1978) 37.13
Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem (1973) 24.38
Charon phages: safer derivatives of bacteriophage lambda for DNA cloning. Science (1977) 20.27
Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA. Cell (1979) 19.98
Are snRNPs involved in splicing? Nature (1980) 15.47
Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell (1978) 13.33
EK2 derivatives of bacteriophage lambda useful in the cloning of DNA from higher organisms: the lambdagtWES system. Science (1977) 13.24
A physical map of the DNA regions flanking the rabbit beta-globin gene. Cell (1977) 12.96
Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase. Biochim Biophys Acta (1976) 12.73
Coincidence of the promoter and capped 5' terminus of RNA from the adenovirus 2 major late transcription unit. Cell (1978) 9.60
Organisation and sequences at the 5' end of a cloned complete ovalbumin gene. Nature (1979) 9.30
Conservation of the primary structure at the 3' end of 18S rRNA from eucaryotic cells. Cell (1978) 8.98
The evolution and sequence comparison of two recently diverged mouse chromosomal beta--globin genes. Cell (1979) 8.11
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77
Analysis of unintegrated avian RNA tumor virus double-stranded DNA intermediates. J Virol (1978) 7.06
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A (1980) 6.73
Viral integration and excision: structure of the lambda att sites. Science (1977) 6.66
Bacteriophage T7 early promoters: nucleotide sequences of two RNA polymerase binding sites. J Mol Biol (1975) 6.52
The complete sequence of a chromosomal mouse alpha--globin gene reveals elements conserved throughout vertebrate evolution. Cell (1979) 6.05
Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95
Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell (1979) 5.28
Nucleotide sequence of Xenopus borealis oocyte 5S DNA: comparison of sequences that flank several related eucaryotic genes. Cell (1978) 4.55
Analysis of integrated avian RNA tumor virus DNA in transformed chicken, duck and quail fibroblasts. J Virol (1979) 4.34
DNA sequence at the integration sites of the insertion element IS1. Cell (1978) 4.27
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J Virol (1979) 3.90
RNA synthesis in isolated nuclei: in vitro initiation of adenovirus 2 major late mRNA precursor. Proc Natl Acad Sci U S A (1979) 3.75
Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse. Cell (1979) 3.63
IS1 insertion generates duplication of a nine base pair sequence at its target site. Cell (1978) 3.55
Mapping of linear and circular forms of mouse mammary tumor virus DNA with restriction endonucleases: evidence for a large specific deletion occurring at high frequency during circularization. Proc Natl Acad Sci U S A (1978) 3.45
Structural analysis of the fibroin gene at the 5' end and its surrounding regions. Cell (1979) 3.16
Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature (1979) 3.15
Unusual features in the nucleotide sequence of a cDNA clone derived from the common region of avian sarcoma virus messenger RNA. Proc Natl Acad Sci U S A (1980) 2.45
Single base-pair alterations in the Escherichia coli trp operon leader region that relieve transcription termination at the trp attenuator. Proc Natl Acad Sci U S A (1978) 2.36
Translocation specificity of the Tn3 element: characterization of sites of multiple insertions. Cell (1980) 2.31
Tissue culture studies of mouse mammary tumor cells and associated viruses. J Natl Cancer Inst (1972) 2.22
Mouse mammary tumor virus DNA in infected rat cells: characterization of unintegrated forms. Cell (1977) 2.11
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. Proc Natl Acad Sci U S A (1979) 2.08
In vitro system for production of mouse mammary tumor virus. Appl Microbiol (1974) 1.54
Interaction between viral and genetic factors in murine mammary cancer. Adv Cancer Res (1978) 1.51
High frequency variation in mammary tumor virus expression in cell culture. Cell (1976) 1.29
Molecular structure and flanking nucleotide sequences of the natural chicken ovomucoid gene. Cell (1979) 1.27
A method for classification of 5' termini of retroviruses. Nature (1978) 1.23
Unlinked control of multiple glucocorticoid-induced processes in HTC cells. Mol Cell Endocrinol (1979) 1.07
Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences. Cold Spring Harb Symp Quant Biol (1980) 1.01
Variants of HTC cells with low tyrosine aminotransferinase inducibility and apparently normal glucorticoid receptors. Endocrinology (1977) 0.94
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68
The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science (2000) 6.17
A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. Proc Natl Acad Sci U S A (1984) 5.81
Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J Virol (1980) 4.91
Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc Natl Acad Sci U S A (1980) 4.71
Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell (1981) 4.67
Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J (1987) 4.60
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene (1993) 4.03
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J Virol (1979) 3.90
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell (1987) 3.74
Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science (1992) 3.13
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12
Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr Biol (2001) 3.09
Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J Microsc (2003) 2.74
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62
Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J (1993) 2.57
Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol (1991) 2.56
Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc Natl Acad Sci U S A (1996) 2.52
Functional organization of the Harvey murine sarcoma virus genome. J Virol (1980) 2.46
Large-scale chromatin decondensation and recondensation regulated by transcription from a natural promoter. J Cell Biol (2001) 2.43
The transcriptionally-active MMTV promoter is depleted of histone H1. Nucleic Acids Res (1992) 2.16
Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem (1997) 2.11
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00
Continuity of care and the physician-patient relationship: the importance of continuity for adult patients with asthma. J Fam Pract (2000) 1.95
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem (2000) 1.77
Nucleosome positioning on the MMTV LTR results from the frequency-biased occupancy of multiple frames. Genes Dev (1995) 1.74
Specific transcriptional initiation in vitro on murine type C retrovirus promoters. Proc Natl Acad Sci U S A (1981) 1.71
Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods (1999) 1.71
Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci (1996) 1.68
Glucocorticoid regulation of transcription at an amplified, episomal promoter. Mol Cell Biol (1983) 1.66
Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc Natl Acad Sci U S A (1993) 1.62
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc Natl Acad Sci U S A (1996) 1.62
Further evidence for the protein coding potential of the mouse mammary tumor virus long terminal repeat: nucleotide sequence of an endogenous proviral long terminal repeat. J Virol (1983) 1.59
Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc Natl Acad Sci U S A (1990) 1.58
Analysis of human immunodeficiency virus type 1 integrase mutants. Virology (1995) 1.58
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A (2000) 1.54
Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science (1990) 1.52
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet (1995) 1.49
Molecular cloning of the Harvey sarcoma virus circular DNA intermediates. II. Further structural analyses. J Virol (1980) 1.45
Retroviral DNA integrated during infection by an integration-deficient mutant of murine leukemia virus is oligomeric. J Virol (1987) 1.44
Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol (1996) 1.44
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Binding of multiple factors to the MMTV promoter in crude and fractionated nuclear extracts. Nucleic Acids Res (1988) 1.41
p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev (1996) 1.41
Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell (1999) 1.40
Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res (1995) 1.40
Modulation of enhancer activity by the hormone responsive regulatory element from mouse mammary tumor virus. EMBO J (1984) 1.40
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene (1995) 1.35
Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Mol Cell Biol (1991) 1.34
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res (1995) 1.32
A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. J Virol (1997) 1.31
Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Mol Endocrinol (1994) 1.31
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene (1995) 1.30
The position and length of the steroid-dependent hypersensitive region in the mouse mammary tumor virus long terminal repeat are invariant despite multiple nucleosome B frames. Mol Cell Biol (1998) 1.30
The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol (2001) 1.24
Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene (1994) 1.24
p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci (1999) 1.24
Molecular structure of yeast RNA polymerase III: demonstration of the tripartite transcriptive system in lower eukaryotes. Proc Natl Acad Sci U S A (1976) 1.23
Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol (1995) 1.20
Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol (2000) 1.17
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model. Cell Growth Differ (1999) 1.16
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene (2000) 1.15
Characterization of purified poly(adenylic acid)-containing messenger ribonucleic acid from Saccharomyces cerevisiae. Biochemistry (1977) 1.15
Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol (1999) 1.12
Transcriptional state of the mouse mammary tumor virus promoter can affect topological domain size in vivo. J Biol Chem (1999) 1.11
The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. Genomics (2000) 1.10
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res (1995) 1.10
Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J Biol Chem (2001) 1.10
Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol (1994) 1.08
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene (2010) 1.08
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol (1988) 1.07
Unlinked control of multiple glucocorticoid-induced processes in HTC cells. Mol Cell Endocrinol (1979) 1.07
The mouse mammary tumor virus model in studies of glucocorticoid regulation. Recent Prog Horm Res (1984) 1.06
Histone hyperacetylation does not alter the positioning or stability of phased nucleosomes on the mouse mammary tumor virus long terminal repeat. Biochemistry (1991) 1.06
Mouse models in tumor suppression. Oncogene (1998) 1.04
Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem (1998) 1.03
p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc Natl Acad Sci U S A (1995) 1.02
Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences. Cold Spring Harb Symp Quant Biol (1980) 1.01
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth Differ (1997) 1.01
Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Oncogene (2000) 1.00
Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo. Mol Cell Biol (1995) 1.00
Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene (1994) 0.99
Transcription of yeast DNA by homologous RNA polymerases I and II: selective transcription of ribosomal genes by RNA polymerase I. Biochemistry (1977) 0.99
Induction of developmentally programmed cell death and activation of HIV by sodium butyrate. Virology (1994) 0.99
The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropin-releasing hormone distal negative glucocorticoid response element. J Biol Chem (1999) 0.99
Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway. Mol Cell Biol (1995) 0.98
Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing. Toxicol Pathol (2001) 0.96
Nucleosomes reconstituted in vitro on mouse mammary tumor virus B region DNA occupy multiple translational and rotational frames. Biochemistry (1995) 0.96
Androgen suppressed apoptosis is modified in p53 deficient mice. Oncogene (1995) 0.95
Analysis of in vivo nucleosome positions by determination of nucleosome-linker boundaries in crosslinked chromatin. Methods (1997) 0.95
Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS. J Virol (1991) 0.95
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Res (1996) 0.93
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol Carcinog (1994) 0.92
Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: II. Receptor-antiglucocorticoid complexes do not interact productively with mouse mammary tumor virus long terminal repeat chromatin. Mol Endocrinol (1987) 0.92